GO
Loading...

European Stocks to Watch: GlaxoSmithKline

Shares in GlaxoSmithKline fell 0.4% as the British pharmaceutical giant came under fire for allegedly misleading its shareholders about safety concerns facing its diabetes drug Avandia.

Kaplan Fox & Kilsheimer filed a class-action suit in the U.S. District Court for the Southern District of New York against GSK, the law firm said in a statement Tuesday.

The law firm is claiming that some results from analysis of the drug's heart-attack risk weren't adequately disclosed to the investing public, Reuters reported.

BP (Up 0.1%) The London-listed oil major is one of four companies shortlisted to partner with Gazprom in the $3.7 billion liquefied natural gas plant on the Baltic Sea, the Russian gas monopoly's deputy chief executive told Reuters.

Biffa (Down 9%) Shares in the British waste firm sank despite an 11% rise in annual profit, as Citigroup cut its price target for the shares to 345 pence from 370 pence due to moderate growth expectations.

Debenhams (Up 1.8%) The U.K. chain store gained on news an investment vehicle of Icelandic group Baugur built up a 4.87% stake in the company, Reuters reported.

Sanofi-Aventis (Down 0.8%) The U.S. Food and Drug Administration delivered another blow to the CAC-40-listed drug maker, as results from clinical trials showed people who took the obesity pill Zimulti were more likely to report suicidal thoughts or actions, traders told Reuters.

Symbol
Price
 
Change
%Change
GSK
---

Featured

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video